STAAR Surgical Company

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems. The company is a leading manufacturer of phakic implantable lenses used globally in corrective or "refractive" surgery, with over 40 years dedicated to ophthalmic surgery. STAAR generates worldwide revenue almost exclusively from sales of its Implantable Collamer Lenses, or "ICLs." These ICLs are made from Collamer, a proprietary collagen copolymer material created and exclusively used by STAAR, making the lenses soft, flexible, and biocompatible with the eye. ICLs are phakic lenses, implanted into the eye without removing the natural crystalline lens, distinguishing them from other refractive procedures that involve corneal tissue removal. All ICLs are foldable, allowing for insertion through a small incision during minimally invasive surgery. While intended to be permanent, STAAR's ICLs are reversible lens implants. The company markets and sells its "EVO" family of lenses for refractive surgery to treat myopia (nearsightedness), which includes the EVO ICL, EVO+ ICL, and EVO Visian ICL. The newest offering, EVO Viva, features an extended depth of focus (EDoF) optic designed to treat myopia with presbyopia (age-related loss of ability to focus). STAAR also markets and sells an ICL lens called Visian ICL to treat hyperopia (farsightedness).